肌少症筛查工具。
Screening Tools for Sarcopenia.
机构信息
The Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan;
The Premier Departmental Research of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
出版信息
In Vivo. 2021 Nov-Dec;35(6):3001-3009. doi: 10.21873/invivo.12595.
Abstract
The elderly people are characterized by multiple comorbidities, dementia, and are at risk of developing sarcopenia and frailty. Sarcopenia is defined by loss of muscle mass and muscle strength or physical decline. Sarcopenia is a main component of physical frailty. Screening tools for sarcopenia that can be easily determined in daily practice are useful and include the SARC-F screening tool. SARC-F is a questionnaire consisting of five questions: Strength (S), Assistance walking (A), Rising from a chair (R), Climbing stairs (C), and Falls (F) on a scale of 0 to 2. The recommended cutoff value is ≥4 points. The SARC-F has been shown to correlate well with clinical outcomes in the elderly and various underlying diseases, while it is also true that the SARC-F has its shortcomings such as low sensitivity for sarcopenia. In this review, we mainly outline the SARC-F and mention other screening tools for sarcopenia.
摘要
老年人的特点是多种合并症、痴呆症，并且有发生肌少症和衰弱的风险。肌少症的定义是肌肉质量和肌肉力量的丧失或身体衰退。肌少症是身体虚弱的主要组成部分。在日常实践中，可以通过简单确定的肌少症筛查工具很有用，包括 SARC-F 筛查工具。SARC-F 是一个由五个问题组成的问卷：力量（S）、助行（A）、从椅子上站起来（R）、爬楼梯（C）和跌倒（F），每个问题的得分范围为 0 到 2。建议的截断值为≥4 分。SARC-F 已被证明与老年人和各种基础疾病的临床结局密切相关，而 SARC-F 也有其缺点，如对肌少症的敏感性低。在这篇综述中，我们主要概述了 SARC-F 并提到了其他肌少症筛查工具。
相似文献
1
Screening Tools for Sarcopenia.肌少症筛查工具。
In Vivo. 2021 Nov-Dec;35(6):3001-3009. doi: 10.21873/invivo.12595.
2
SARC-F as a Useful Tool for Screening Sarcopenia in Elderly Patients with Hip Fractures.SARC-F 作为一种有用的工具，用于筛查髋部骨折老年患者的肌少症。
J Nutr Health Aging. 2020;24(1):78-82. doi: 10.1007/s12603-019-1307-6.
3
Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.《评估肌少症的 SARC-F 问卷韩国版的验证：韩国虚弱与衰老队列研究》。
J Am Med Dir Assoc. 2018 Jan;19(1):40-45.e1. doi: 10.1016/j.jamda.2017.07.006. Epub 2017 Aug 31.
4
Comparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons.社区居住老年人肌少症三种筛查方法的比较。
J Am Med Dir Assoc. 2021 Apr;22(4):746-750.e1. doi: 10.1016/j.jamda.2020.05.041. Epub 2020 Jul 12.
5
Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study.SARC-F 问卷筛查的肌少症与老年女性的身体表现：一项横断面研究。
J Am Med Dir Assoc. 2017 Oct 1;18(10):848-852. doi: 10.1016/j.jamda.2017.05.010. Epub 2017 Jun 16.
6
A comparative study of the sarcopenia screening in older patients with interstitial lung disease.老年间质性肺疾病患者肌少症筛查的比较研究。
BMC Pulm Med. 2022 Jan 25;22(1):45. doi: 10.1186/s12890-022-01840-3.
7
SARC-F and SARC-CalF in screening for sarcopenia in older adults with Parkinson's disease.SARC-F 和 SARC-CalF 在帕金森病老年患者肌少症筛查中的应用。
Exp Gerontol. 2021 Feb;144:111183. doi: 10.1016/j.exger.2020.111183. Epub 2020 Dec 3.
8
SARC-F Is Inaccurate to Identify Geriatric Rehabilitation Inpatients at Risk for Sarcopenia: RESORT.SARC-F 无法准确识别老年康复住院患者的肌少症风险：RESORT 研究。
Gerontology. 2022;68(3):252-260. doi: 10.1159/000516117. Epub 2021 Jun 1.
9
Validating the SARC-F: a suitable community screening tool for sarcopenia?验证SARC-F：一种适用于肌少症的社区筛查工具？
J Am Med Dir Assoc. 2014 Sep;15(9):630-4. doi: 10.1016/j.jamda.2014.04.021. Epub 2014 Jun 16.
10
Practical screening tools for sarcopenia in patients with systemic sclerosis.实用的系统性硬化症患者肌少症筛查工具。
PLoS One. 2021 Jan 22;16(1):e0245683. doi: 10.1371/journal.pone.0245683. eCollection 2021.
引用本文的文献
1
Sarcopenia and Pleural Effusions: Exploring a Potential Link.肌肉减少症与胸腔积液：探索潜在联系
Muscles. 2024 Jun 22;3(3):189-201. doi: 10.3390/muscles3030017.
2
Sarcopenia and Pleural Mesothelioma: The Current Knowledge.肌肉减少症与胸膜间皮瘤：当前认知
Muscles. 2024 Feb 8;3(1):48-59. doi: 10.3390/muscles3010006.
3
Frailty in COPD: Clinical Impact, Diagnosis, Biomarkers, and Management Strategies.慢性阻塞性肺疾病中的衰弱：临床影响、诊断、生物标志物及管理策略
Int J Chron Obstruct Pulmon Dis. 2025 Jul 15;20:2445-2458. doi: 10.2147/COPD.S522862. eCollection 2025.
4
Comparing efficacy of different scoring models to predict hepatic encephalopathy after TIPS in cirrhotic patients.比较不同评分模型预测肝硬化患者经颈静脉肝内门体分流术后肝性脑病的疗效。
Ann Med. 2025 Dec;57(1):2514082. doi: 10.1080/07853890.2025.2514082. Epub 2025 Jun 6.
5
The current clinical management of muscle wasting in hemodialysis patients with end-stage renal disease.终末期肾病血液透析患者肌肉消耗的当前临床管理。
Int Urol Nephrol. 2025 May 27. doi: 10.1007/s11255-025-04563-6.
6
The predictive values of sarcopenia screening tools in preoperative elderly patients with colorectal cancer: applying the diagnostic criteria of EWGSOP2 and AWGS2019.肌肉减少症筛查工具在老年结直肠癌患者术前的预测价值：应用EWGSOP2和AWGS2019诊断标准
BMC Geriatr. 2025 Mar 28;25(1):206. doi: 10.1186/s12877-025-05806-y.
7
Determinants of dementia risk among older adults with probable sarcopenia and sarcopenia.可能患有肌肉减少症和肌肉减少症的老年人痴呆风险的决定因素。
BMC Public Health. 2025 Mar 25;25(1):1139. doi: 10.1186/s12889-025-22065-z.
8
Fndc5/irisin mediates the benefits of aerobic exercise intervention on aging-associated sarcopenia in mice.Fndc5/鸢尾素介导有氧运动干预对小鼠衰老相关肌肉减少症的益处。
Eur Geriatr Med. 2025 Mar 13. doi: 10.1007/s41999-025-01181-4.
9
Impact of sarcopenia on outcomes following vertebral augmentation for osteoporotic vertebral compression fracture: a systematic review and meta-analysis.肌肉减少症对骨质疏松性椎体压缩骨折椎体强化术后结局的影响：一项系统评价和荟萃分析
Asian Spine J. 2025 Jun;19(3):476-489. doi: 10.31616/asj.2024.0467. Epub 2025 Mar 4.
10
Diagnostic accuracy analysis of SARC-F, its modified versions and the Quality of Life in Sarcopenia questionnaire in screening for sarcopenia in nursing home residents.简易体能状况量表（SARC-F）及其修订版和肌少症生活质量问卷对养老院居民肌少症筛查的诊断准确性分析
Geriatr Gerontol Int. 2024 Dec;24(12):1335-1342. doi: 10.1111/ggi.15020. Epub 2024 Nov 18.
本文引用的文献
1
Comparison of SARC-F Score among Gastrointestinal Diseases.胃肠道疾病中SARC-F评分的比较
J Clin Med. 2021 Sep 10;10(18):4099. doi: 10.3390/jcm10184099.
2
Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan.SARC-F问卷在慢性肝病患者肌肉减少症筛查中的应用：日本一项多中心横断面研究
J Clin Med. 2021 Aug 3;10(15):3448. doi: 10.3390/jcm10153448.
3
Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis.SARC-F 及其修订版的可靠性和同时效度的系统评价和荟萃分析。
J Am Med Dir Assoc. 2021 Sep;22(9):1864-1876.e16. doi: 10.1016/j.jamda.2021.05.011. Epub 2021 Jun 16.
4
The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan.SARC-F 量表在预测老年 COVID-19 患者进展风险中的作用：武汉的一项前瞻性队列研究。
BMC Geriatr. 2021 Jun 10;21(1):355. doi: 10.1186/s12877-021-02310-x.
5
Validation of the SARC-F for Assessing Sarcopenia in Patients on Peritoneal Dialysis.用于评估腹膜透析患者肌肉减少症的SARC-F量表的验证
J Ren Nutr. 2022 May;32(3):341-346. doi: 10.1053/j.jrn.2021.03.012. Epub 2021 May 28.
6
Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission.在 COVID-19 患者住院期间和出院后，普遍存在营养状况不佳、肌少症风险和与营养相关的投诉。
Clin Nutr ESPEN. 2021 Jun;43:369-376. doi: 10.1016/j.clnesp.2021.03.021. Epub 2021 Apr 20.
7
Sarcopenia and Frailty in Liver Cirrhosis.肝硬化中的肌肉减少症和衰弱症
Life (Basel). 2021 Apr 27;11(5):399. doi: 10.3390/life11050399.
8
SARC-F Questionnaire Detects Frailty in Older Adults.SARC-F问卷可检测老年人的虚弱状况。
J Nutr Health Aging. 2021;25(4):448-453. doi: 10.1007/s12603-020-1543-9.
9
Clinical impact of the finger-circle test in patients with liver diseases.指圈试验对肝病患者的临床影响。
Hepatol Res. 2021 May;51(5):603-613. doi: 10.1111/hepr.13639. Epub 2021 Apr 5.
10
Practical screening tools for sarcopenia in patients with systemic sclerosis.实用的系统性硬化症患者肌少症筛查工具。
PLoS One. 2021 Jan 22;16(1):e0245683. doi: 10.1371/journal.pone.0245683. eCollection 2021.
Zotero 插件